European Cornea Experts Survey
Gene Signal has conducted a survey among members of the European Society of Ocular and Surface Disease Specialists (EUCORNEA) and of the European Eye Bank Association (EEBA). Topics included indications for keratoplasty, surgical techniques and management of patients with pre-graft corneal neovascularization.
Gene Signal has collected responses from 34 major European centres, corresponding to approximately 15 to 25% of the 20,000 keratoplasty procedures performed in the EU annually.
The outcome of this survey has provided a clear picture of the current medical practice in the EU, and will be instrumental in the design of the upcoming Phase III pivotal clinical trial with aganirsen 0.86 mg/mL eye drops. This survey also showed the continued interest of the EU cornea experts in aganirsen.